Back
Relmada Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
RLMD
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
34
RLMD
Relmada Therapeutics
Last Price:
3.43
Seasonality Move:
-1.84%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Relmada Therapeutics Price Quote
$3.43
-0.01 (-1.72%)
(Updated: November 5, 2024 at 5:40 AM ET)
Relmada Therapeutics Key Stats
Sell
34
Relmada Therapeutics (RLMD)
is a Sell
Day range:
$3.36 - $3.67
52-week range:
$1.88 - $7.22
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.69%
Volume:
113.4K
Avg. volume:
121.9K
1-year change:
8.86%
Market cap:
$103.8M
Revenue:
$0
EPS:
$-2.87
How Much Does Relmada Therapeutics Make?
Data Unavailable
Is Relmada Therapeutics Growing As A Company?
Data Unavailable
Relmada Therapeutics Stock Price Performance
-
Did Relmada Therapeutics Stock Go Up Last Month?
Relmada Therapeutics share price went down by -1.15% last month -
Did RLMD's Share Price Rise Over The Last Year?
RLMD share price rose by 8.86% over the past 1 year
What Is Relmada Therapeutics 52-Week High & Low?
-
What Is Relmada Therapeutics’s 52-Week High Share Price?
Relmada Therapeutics has traded as high as $7.22 over the past 52 weeks -
What Is Relmada Therapeutics’s 52-Week Low Share Price?
Relmada Therapeutics has traded as low as $1.88 over the past 52 weeks
Relmada Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Relmada Therapeutics?
-
How Much Debt Does Relmada Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Relmada Therapeutics Have?
Cash and short term investments quarterly total is $70.4M -
What Is Relmada Therapeutics’s Book Value Per Share?
Book value per share is 2.04
Is Relmada Therapeutics Cash Flow Positive?
-
What Is RLMD Cash Flow From Operations?
Cash flow from operations (TTM) is -$48.2M -
What Is Relmada Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $123.3K -
What Is Relmada Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $35.7M
Relmada Therapeutics Return On Invested Capital
Data Unavailable
Relmada Therapeutics Earnings Date & Stock Price
-
What Is Relmada Therapeutics's Stock Price Today?
A single share of RLMD can be purchased today for 3.44 -
What Is Relmada Therapeutics’s Stock Symbol?
Relmada Therapeutics trades on the nasdaq under the ticker symbol: RLMD -
When Is Relmada Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Relmada Therapeutics is scheduled on November 8, 2024 -
When Is RLMD's next ex-dividend date?
Relmada Therapeutics's next ex-dividend date is November 5, 2024 -
How To Buy Relmada Therapeutics Stock?
You can buy Relmada Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Relmada Therapeutics Competitors
-
Who Are Relmada Therapeutics's Competitors?
Below is a list of companies who compete with Relmada Therapeutics or are related in some way:
Relmada Therapeutics Dividend Yield
-
What Is RLMD Dividend Yield?
Relmada Therapeutics’s dividend yield currently is 0% -
What Is Relmada Therapeutics’s Payout Ratio?
Relmada Therapeutics’s payout ratio is 0% -
When Did Relmada Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is Relmada Therapeutics’s Dividend Per Share?
Relmada Therapeutics pays a dividend of $0.00 per share
Relmada Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 12.50 |
Upside from Last Price: | 263.37% |